OM1 to Present Research on Multiple Sclerosis at ACTRIMS Forum 2024
The poster will focus on the use of an AI based estimation model used to help characterize disease progression in multiple sclerosis (MS) subtypes using real-world data (RWD).
- The poster will focus on the use of an AI based estimation model used to help characterize disease progression in multiple sclerosis (MS) subtypes using real-world data (RWD).
- WHEN: The presentation will be held on the first day of ACTRIMS Forum 2024 on Thursday, February 29 between 6:00 – 7:30 pm ET.
- WHY: To effectively monitor disease progression in patients with MS, the measurement of disability is an important component.
- For insights specific to OM1’s work with multiple sclerosis, including the company’s PremiOM MS dataset, visit the website page here .